NovoCure
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.About NVCR
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.
NVCR Key Statistics
Stock Snapshot
The current NovoCure(NVCR) stock price is $13.69, with a market capitalization of 1.53B. The stock trades at a price-to-earnings (P/E) ratio of -8.46.
As of 2026-01-18, NovoCure(NVCR) stock has fluctuated between $13.50 and $14.07. The current price stands at $13.69, placing the stock +1.4% above today's low and -2.7% off the high.
The NovoCure(NVCR)'s current trading volume is 792.01K, compared to an average daily volume of 1.25M.
In the last year, NovoCure(NVCR) shares hit a 52-week high of $27.47 and a 52-week low of $10.70.
In the last year, NovoCure(NVCR) shares hit a 52-week high of $27.47 and a 52-week low of $10.70.
NVCR News
NovoCure (NVCR) has drawn fresh attention after reporting record 2025 revenues of $655 million, appointing Frank Leonard as CEO, and advancing FDA submissions f...
If you are trying to figure out whether NovoCure at around US$14.18 is a potential bargain or a value trap, you are in the right place. The share price has bee...
Reports Preliminary FY25 revenue $655.4M, consensus $651.21M. “Novocure (NVCR) exits 2025 having achieved record annual revenue, providing the financial strengt...